Sofia R Fernandez, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 137 Smithfield Court, Basking Ridge, NJ 07920 Phone: 908-803-9985 |
Joseph Morandi, D.O Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 665 Martinsville Rd, Suite 218, Basking Ridge, NJ 07920 Phone: 908-607-1877 Fax: 908-607-1866 |
Dr. Domenica Alexandra Fantini, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 665 Martinsville Rd, Suite 218, Basking Ridge, NJ 07920 Phone: 908-607-1877 Fax: 908-607-1866 |
Joseph S Lee, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 48 Juniper Way, Basking Ridge, NJ 07920 Phone: 908-340-4163 |
Beth Anne Kaplan, A-GNP-C Family Medicine - Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 131 Morristown Rd, Basking Ridge, NJ 07920 Phone: 999-999-9999 |
Mr. Sergiusz I Kaftal, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 150 N Finley Ave # 207, Basking Ridge, NJ 07920 Phone: 908-766-1223 |
News Archive
Lippincott Williams & Wilkins (LWW), part of Wolters Kluwer Health, is pleased to announce that seven LWW published journals have won 11 highly regarded awards in this year's Apex Awards for Publication Excellence Competition, recognizing publishing excellence in a variety of categories. Emergency Medicine News took home the esteemed Grand Award for Excellence in the category of 'Magapapers & Newspapers.'
A new project just launched at Karl Landsteiner University of Health Sciences in Krems aims at gaining insights into the development of bone metastases in breast cancer patients and identifying biomarkers as well as new treatment strategies.
Water polo athletes take note: A new study by University of California, Irvine researchers maps out the frequency of head injuries in the sport and reveals which positions are the most vulnerable.
Scil Proteins today announced that it has concluded a financing round with its existing investor, BioNet Holding, worth €24 million. The funds are intended to finance the development of two products derived from the Company's Affilin platform into clinical Phase I over the next three years.
› Verified 8 days ago